Publication - Independent report
Improving equity of access to cancer clinical trials in Scotland
This report summarises the findings and recommendations of an Equity of Access Short Life Working Group. This is provided as a compilation of work package reports.
Appendix 2: Baseline clinical trials staffing data
Ayrshire & Arran, WosCRN
Number of Staff
- Oncologists are visiting clinicians from Beatson
- 2.42wte band 6 nurses
- 0.1wte 8A Pharmacist for CEPA (Regional Chemotherapy Electronic Prescribing and Administration Service) and
- 1.2wte band 5 pharmacists
Funding Source
- 60k from cancer research network- R&D fund the rest
Vacancies/Gaps
- Not able to cover RN annual leave.
- Gaps- band 5 and band 6 nurse gap but no resource
- no resource for data manager
Forth Valley, WosCRN
Number of Staff
- 5 oncology sessions- breast, haematology, Urology, Lung and Colorectal
2 wte research nurses
Funding Source
- some funding from WosCRN, CSO allocation
Vacancies/Gaps
- 1 wte band 7
Greater Glasgow and Clyde, WOsCRN
Number of Staff
- 36 research PAs- oncology consultants
- 2 PA Pathologists
- 3 research fellows
- 0.4 wte Macmillan funded late effect post
- 22.7wte nurses
- 3wte HCSW/sample handlers
- 31.2wte data managers and admin support
- 1.6 wte clinical trial radiographers
- 2.3wte oncology research pharmacists
- 2PAs Beatson Clinical Research Facilities Director
Funding Source
- data manager posts rely on commercial income
- clinical trial radiographers are charity funded -£106884
- R&D fund oncology PAs,50% of research fellows, part of radiographer and radiotherapist posts, band 7 nurse for ATIMPS, oncology research pharmacists and the 2 PAs for Beatson CRF Director
Vacancies
- 1.8wte clinical oncologist vacancies and 1wte medical oncologist vacancy. Plan for further 1.wte medical oncologist post late 2022
- Beatson CRF Quality Manager
Lanarkshire, WosCRN
Number of Staff
- No research-specific funded Oncology sessions - Oncologists are visiting clinicians from NHS GG&C (Beatson). Service scope – including service levels and services provided - fall under a Service Level Agreement.
- Solid tumours:2.50 WTE Band 6 RN,
- Haematological cancer:1.6 WTE Band 6 RN
Funding Source
- 45% of nurse post funding is from WosCRN, rest R&D
Vacancies/Gaps
- No Research Nurse gaps for Cancer Clinical Trials at the present level of recruitment / activity.
- Gap identifed that would require funding- band 5 clinical trials aseptic pharmacy technician 0.5wte £21645 and band 7 clinical trials aseptic pharmacist 0.5 wte £31775
Grampian, NOSCRN
Number of Staff
- 2 NRS fellowships for breast cancer surgeons and 1 NRS fellowship for GP in cancer - as well as 8.9 sessions for oncologists and 3.7 sessions for haematologists
- 11.2wte nurses, 1.2 wte HCSW
- 7.8 wte data managers
Funding Source
- Funding from NOSCRN support 3.63wte nurses.
- Other posts are funded by R&D and endowments.
- PA sessions for clinicians are a mixture of funding sources including grant, commercial, NHS, academic and research
Vacancies/Gaps
- Consultant vacancies in oncology
Highland, NOSCRN
Number of Staff
- No information on number of oncology sessions
- 4.29wte nurses
- 3.8wte data managers
Funding Source
- Funding from NOSCRN supports
- 0.8wte nurse and 2.2wte data managers.
- Other posts are funded by R&D
Vacancies/Gaps
- Consultant vacancies in oncology
Tayside, NOSCRN
Number of Staff
- NRS researcher support for 9 consultants comprising 18 PAs- 2 Oncologists, 2 Radiologists, 3 Surgeons, 1 Pathologist and 1 Haematologist
- 4.4 FTE nurses
- 2.7 FTE data managers
Funding Source
- Consultant PAs funded through R&D, and academic grants
- Research Nurses: 1.6FTE SCRN, 1.8 R&D 1.0 endowments/Trial income/academic grants/commercial trial income
- Data Mangers: 0.99 FTE SCRN 0.9 FTE R&D, 0.81 FTE endowments/Trial income/ grants
Vacancies/Gaps
- 5.0FTE Oncology consultant vacancies
Borders, SECRN
Number of Staff
- Oncologists are visiting clinicians from Lothian-2 clinical oncologist sessions -breast and lung
- 1.2 wte nursing (0.4 wte supports other areas as well)
- 0.4wte data manager and 0.4wte admin (admin supports other areas)
Funding Source
- 20k from SECRN and CSO allocation total cost of nurse posts for 2022/23 is £83209
Vacancies/Gap
- Band 6 1wte research pharmacy post remains unfilled - currently funding band 5 resource to cover
- Lung oncologist is not research active in NHS Borders
- Haematology vacancies- difficulty recruiting to not able to cover RN annual leave
Dumfies & Galloway, SECRN
Number of Staff
- No information on number of oncology sessions
- 0.6wtenurse,
- 1wte data manager
- 1 wte admin support
Funding Source
- Nurse funded by SECRN
Vacancies/Gaps
- No R&D manager
- No current breast oncologist cover
Fife, SECRN
Number of Staff
- No information on number of oncology sessions
- 3.4 wte nurse and support staff
- 0.5wte pharmacist and 0.6wte pharmacy technicians
Funding Source
- 0.8wte haematology and oncology research nurse funding from SECRN, R&D funds remaining 2.6wte
- R&D fund pharmacy posts
Vacancies/Gaps
- pharmacist post vacant for long period- due to be filled in March 2022 0.5 wte but supports all research
Lothian, SECRN
Number of Staff
- 2 NRS fellowships for cancer, plus haematologist and urological surgeon whose research programmes focus on cancer. 8 oncologists with ring-fenced research time (most are ex-NRS fellows)
- 23.2 wte nurses
- 19.0wte data managers
- 1.0wte EDGE manager
- 6.0wte Tissue consenter/processors
- 1.0wte Pharmacy technician
Funding Source
- Funding from SECRN, CRUK, ECMC, commercial and non-commercial income and R&D, drugs saving reinvested by service into trials pharmacy support
Vacancies/Gaps
- 3.0wte nurse vacancies + supporting SACT Standard of care service due to vacancies there
- 2.0wte data manager vacancies, consultant vacancies in Oncology and Haematology
Contact
Email: cancerpolicyteam@gov.scot
There is a problem
Thanks for your feedback